期刊文献+

Notch信号对大鼠肝纤维化Th17/Treg平衡的影响 被引量:4

The effect of Notch signaling on Th17/Treg balance in rat liver fibrosis
下载PDF
导出
摘要 目的建立大鼠肝纤维化模型,探讨Notch信号在肝纤维化模型中的作用及对Th17/Treg细胞平衡的影响。方法40只Wistar雄性大鼠随机分为对照组(10只)、模型组(30只)。用刀豆蛋白A(Con A)建模,8周建模成功后模型组随机分成3组(PAPT组、TGFβ组、DMSO对照组),10只/组,并对其体外心尖取血3 ml,分离外周单个核细胞(PBMC),用Notch抑制剂DAPT及TGF-β抑制剂干预培养24 h,RT-PCR测Notch信号及TGF-β相关基因表达,流式细胞术测Th17和Treg细胞频率,ELISA法测PBMC培养上清中细胞因子IL-17、IL-23、TGF-β及IL-10的表达。结果与对照组相比,干预组Notch和TGF-β信号相关基因表达显著降低(P<0.05)。Th17细胞频率及其相关因子(IL-17、IL-23)水平降低(P<0.05),Treg细胞频率及其相关因子(TGF-β、IL-10)水平明显降低(P<0.05),Th17/Treg比值较对照组上升(P<0.05)。结论 Notch信号参与肝纤维化的发生发展,阻断Notch信号能抑制Treg细胞功能,降低TGF-β1水平,为肝纤维化的治疗研究提供实验基础。 To explore the role of Notch signaling in liver fibrosis and its effect on Thl7/Treg balance, 40 male Wistar rats were recruited and randomly divided into control group (n=10) and model group (n=30). The liver fibrosis model was built with ConA, then randomly divided into 3 subgroups as DAPT (n=10), TGF-β inhibitor (n=10) and DMSO (n=10) after 8 weeks modeling success. 3 ml blood was gathered by apex eordis from model group; peripheral blood monouclear cells (PBMC) were separated and cultured by DAPT and TGF-13 inhibitor for 24 h. RT-PCR was performed to analyze the relative mRNA level of Notch and TGF-β signaling; the frequencies of Th17 and Treg in PBMC were measured by flow cytometry (FCM), and the levels of IL-17, IL-23, IL-10 and TGF-β1 in the culture supernatant were measured by ELISA. Compared with DMSO group, the relative mRNA expression of Notch and TGF-β signaling in DAPT group and TGF-β inhibitor group decreased significantly (P〈0.05), the frequency of Th17 and its cytokines (IL-17, IL-23) were lower (P〈0.05), while the frequency of Treg and its cytokines (IL-10, TGF-β1) were lower markedly(P〈0.05). Furthermore, the ratio of Th17/Treg increased in DAPT group and TGF-β inhibitor group compared with DMSO control group. In conclusion, blocking Notch signaling can inhibit Treg cell function and reduce the level of TGF-β1, which maybe a valuable tool of research for liver fibrosis treatment in the future.
出处 《免疫学杂志》 CAS CSCD 北大核心 2016年第8期666-670,共5页 Immunological Journal
基金 山东省自然科学基金(2014ZRB01466)
关键词 肝纤维化 NOTCH TGF-Β1 TH17 TREG Liver fibrosis Notch TGF-β1 Th17 Treg
  • 相关文献

参考文献19

  • 1Hernandez Gea V, Friedman SL. Pathogenesis of liver fibrosis[J]. Annu Rev Pathol, 2011, 6:425-456.
  • 2Friedman SL. Mechanisms of hepatic fibrogenesis[J]. Gastroenterology, 2008, 134(6): 1655-1669.
  • 3张文,张蓓,沈若武,高美华,李秀梅,丛蓓蓓,王丽娜,李晨雨.Tim-3及Th17细胞在免疫性肝损伤中的动态研究[J].免疫学杂志,2014,30(12):1053-1056. 被引量:2
  • 4王十锦,张蓓,王丽,梁洁,耿霄,周文超.大鼠肝损伤模型中Th17/Treg失衡的研究[J].免疫学杂志,2014,30(2):133-138. 被引量:16
  • 5耿霄,张蓓,周文超,梁洁,王丽,王十锦.慢性乙型肝炎患者外周血Th17细胞/调节性T细胞比值变化的意义[J].细胞与分子免疫学杂志,2014,30(12):1304-1306. 被引量:11
  • 6Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis[J]. Gut, 2007, 56(2): 284-292.
  • 7Asano N, Watanabe T, Kitani A, et al. Notch1 Signaling and Regulatory T Cell Function[J]. J Immunol, 2008, 180(5): 2796-2804.
  • 8Blokzijl A, Dahlqvist C, Reissmann E, et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad[J]. J Cell Biol, 2003, 163(4): 723-728.
  • 9Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism[J]. Cell, 2009, 137(2): 216-233.
  • 10D' Souza B, Meloty Kapella L, Weinmaster G. Canonical and Non-Canonical Notch Ligands [J]. Curr Top Dev Biol, 2010, 92: 73-129.

二级参考文献24

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:462
  • 2梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 3金玮,杨安怀,邢怡桥.大鼠心脏穿刺采血方法的改进[J].微循环学杂志,2006,16(2):53-55. 被引量:8
  • 4张炜,陈明.腹腔注射刀豆蛋白A诱导昆明小鼠肝纤维化模型的建立[J].免疫学杂志,2007,23(6):687-690. 被引量:6
  • 5Xu DP, Fu JL, Jin L, et al. Circulating and liver resident CD4^+ CD25^+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B [ J ]. J Immunol, 2006, 177 ( 1 ) : 739 - 747.
  • 6Eastaff-Leung N, Mabarraek N, Barbour A, et al. Foxp3 + regulatory T cells, Th17 effeetor cells, and cytokine environment in inflammatory bowel disease[ J]. J Clin Immunol, 2010, 30 (1) : 80- 89.
  • 7Lina C, Conghua W, Nan L, et al. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis[J]. J Clin Immunol, 2011,31 (4) : 596 -605.
  • 8Niu YH, Liu HL, Yin DL, et al. The balance between intrahepatic IL-17^+ T ceils and Foxp3^+ regulatory T calls plays an important role in HBV-related end-stage liver disease [ J ]. BMC Immunol, 2011, 12(47) : 1471 -1479.
  • 9Hao C, Wang J, Kang W, et al. Kinetics of Th17 eytokines during telbivudine therapy in patients with chronic hepatitis B [ J ]. Viral Immunol, 2013, 26(5): 336-342.
  • 10Dong X, Gong Y, Zeng H, et al. Imbalance between circulating CD4^+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure [ J ]. Liver Int, 2013, 33(10) : 1517 -1526.

共引文献34

同被引文献25

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部